Benzinga | Apr 20, 2021 04:16PM EDT

Edwards Lifesciences Q1 EPS $0.54 Beats $0.47 Estimate, Sales $1.22B Beat $1.16B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.47 by 14.89 percent. This is a 64.24 percent decrease over earnings of $1.51 per share from the same period last year. The company reported quarterly sales of $1.22 billion which beat the analyst consensus estimate of $1.16 billion by 4.83 percent. This is a 7.71 percent increase over sales of $1.13 billion the same period last year.